Mecillinam alone and in combination with ampicillin or moxalactam in experimental escherichia coli meningitis

[1]  G. Mccracken,et al.  Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. , 1981, The Journal of infectious diseases.

[2]  Reportofthesecondneonatalmeni INTRAVENTRICULAR GENTAMICIN THERAPY IN GRAM-NEGATIVE BACILLARY MENINGITIS OF INFANCY , 1980 .

[3]  G. Mccracken,et al.  Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis , 1980, Antimicrobial Agents and Chemotherapy.

[4]  R. Moellering Antimicrobial synergism--an elusive concept. , 1979, The Journal of infectious diseases.

[5]  M. Sande,et al.  Mecillinam-Ampicillin Synergism in Experimental Enterobacteriaceae Meningitis , 1979, Antimicrobial Agents and Chemotherapy.

[6]  H. Neu Synergy of Mecillinam, a Beta-Amidinopenicillanic Acid Derivative, Combined with Beta-Lactam Antibiotics , 1976, Antimicrobial Agents and Chemotherapy.

[7]  S. Mize,et al.  A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. , 1976, The Journal of pediatrics.

[8]  H. Neu Mecillinam, a Novel Penicillanic Acid Derivative with Unusual Activity Against Gram-Negative Bacteria , 1976, Antimicrobial Agents and Chemotherapy.

[9]  R. Baltimore,et al.  Synergy of Mecillinam (FL1060) with Penicillins and Cephalosporins Against Proteus and Klebsiella, with Observations on Combinations with Other Antibiotics and Against Other Bacterial Species , 1976, Antimicrobial Agents and Chemotherapy.

[10]  R. Cleeland,et al.  In Vivo Synergy Between 6β-Amidinopenicillanic Acid Derivatives and Other Antibiotics , 1976, Antimicrobial Agents and Chemotherapy.

[11]  N. Melchior,et al.  Mecillinam (FL 1060), a 6β-Amidinopenicillanic Acid Derivative: Bactericidal Action and Synergy In Vitro , 1975, Antimicrobial Agents and Chemotherapy.

[12]  L. Tybring Mecillinam (FL 1060), a 6β-Amidinopenicillanic Acid Derivative: In Vitro Evaluation , 1975, Antimicrobial Agents and Chemotherapy.

[13]  A. Pardee,et al.  Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid , 1975, Journal of bacteriology.

[14]  K. C. Haltalin,et al.  Agar plate dilution method for routine antibiotic susceptibility testing in a hospital laboratory. , 1973, American journal of clinical pathology.

[15]  F. O'grady,et al.  FL 1060: a new beta-lactam antibiotic with novel properties , 1973, Journal of clinical pathology.

[16]  Charles W. Dunnett,et al.  New tables for multiple comparisons with a control. , 1964 .

[17]  E. Steers,et al.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. , 1959, Antibiotics & chemotherapy.

[18]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[19]  G. Mccracken,et al.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. , 1981, The Journal of pediatrics.

[20]  R. Cleeland,et al.  In vivo activity of the 6beta-amidinopenicillanic acid derivative, mecillinam, chemically linked or combined in varying ratios with 6-aminopenicillanic acid derivatives. , 1977, The Journal of antimicrobial chemotherapy.

[21]  B. Spratt The mechanism of action of mecillinam. , 1977, The Journal of antimicrobial chemotherapy.

[22]  H. Neu Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds. , 1977, The Journal of antimicrobial chemotherapy.

[23]  K. E. Price,et al.  Pneumococcal meningitis-therapeutic studies in mice. , 1975, Chemotherapy.

[24]  R. Moellering,et al.  Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. , 1970, Antimicrobial agents and chemotherapy.